期刊文献+

纳武利尤单抗致暴发性免疫相关不良事件1例

Immune-related fulminant adverse events induced by nivolumab:one case report
原文传递
导出
摘要 1例右肺癌患者经纳武利尤单抗治疗后8个月暴发罕见的免疫性心肌炎、免疫性脑炎、免疫性肺炎、免疫性垂体功能减退、免疫性血小板减少、免疫性肝炎的多系统免疫不良反应。分析其病例特征,并与其他免疫检查点抑制剂引起的多系统免疫相关不良事件异同点进行讨论。 After an 8-month therapy of nivolumab,one patient of right lung carcinoma had a rare outbreak of multisystem immune adverse reactions such as immune myocarditis,immune encephalitis,immune pneumonia,immune hypopituitarism,immune thrombocytopenia and immune hepatitis.The clinical characteristics of this case were analyzed along with the similarities and differences with other multi-system immune-related adverse events due to immune checkpoint inhibitors.
作者 孙玲玲 周广洁 张丽娜 李进峰 SUN Lingling;ZHOU Guangjie;ZHANG Lina;LI Jinfeng(Department of Pharmacy,Municipal Hospital,Shandong University,Shandong Weihai 264200,China)
出处 《中国医院药学杂志》 CAS 北大核心 2024年第11期1359-1362,共4页 Chinese Journal of Hospital Pharmacy
关键词 纳武利尤单抗 免疫检查点抑制剂 免疫相关不良事件 nivolumab immune checkpoint inhibitors immune-related adverse events
  • 相关文献

参考文献14

二级参考文献64

共引文献160

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部